Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Jullien

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Antibiotics (Basel, Switzerland)|July 16, 2020
Influence of Renal Function and Age on the Pharmacokinetics of Levofloxacin in Patients with Bone and Joint InfectionsGauthier Eloy, David Lebeaux, Manon Launay, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2018
Successful Treatment of <i>Saksenaea</i> sp. Osteomyelitis by Conservative Surgery and Intradiaphyseal Incorporation of Amphotericin B Cement BeadsPerrine Parize, Anne-Claire Mamez, Dea Garcia-Hermoso, et al.
The Journal of Antimicrobial Chemotherapy|October 5, 2023
Defining standard and high dosages for β-lactam agents administered by intermittent, prolonged or continuous infusion: a PK/PD simulation studySylvain Goutelle, Vincent Jullien, Jean-Pierre Bru, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2019
Low Central Nervous System Posaconazole Concentrations during Cerebral PhaeohyphomycosisFrançois Barde, Eliane Billaud, Lauriane Goldwirt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Predictive factors of virologic success in HIV-1-infected children treated with lopinavir/ritonavirConstance Delaugerre, Jean-Paul Teglas, Jean-Marc Treluyer, et al.
Antimicrobial Agents and Chemotherapy|September 16, 2009
Therapeutic drug monitoring of posaconazole: a monocentric study with 54 adultsDavid Lebeaux, Fanny Lanternier, Caroline Elie, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 29, 2021
Influence of the clindamycin administration route on the magnitude of clindamycin-rifampicin interaction: a prospective pharmacokinetic studyValérie Zeller, Sophie Magreault, Beate Heym, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2018
Is It Time for Systematic Voriconazole Pharmacogenomic Investigation for Central Nervous System Aspergillosis?François Danion, Vincent Jullien, Claire Rouzaud, et al.
The Journal of Antimicrobial Chemotherapy|June 28, 2014
Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in UgandaFrank Kloprogge, Vincent Jullien, Patrice Piola, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Posaconazole Tablets in Real-Life Lung Transplantation: Impact on Exposure, Drug-Drug Interactions, and Drug Management in Lung Transplant Patients, Including Those with Cystic FibrosisManon Launay, Antoine Roux, Laurence Beaumont, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Antibiotics (Basel, Switzerland)|July 16, 2020
Influence of Renal Function and Age on the Pharmacokinetics of Levofloxacin in Patients with Bone and Joint InfectionsGauthier Eloy, David Lebeaux, Manon Launay, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2018
Successful Treatment of <i>Saksenaea</i> sp. Osteomyelitis by Conservative Surgery and Intradiaphyseal Incorporation of Amphotericin B Cement BeadsPerrine Parize, Anne-Claire Mamez, Dea Garcia-Hermoso, et al.
The Journal of Antimicrobial Chemotherapy|October 5, 2023
Defining standard and high dosages for β-lactam agents administered by intermittent, prolonged or continuous infusion: a PK/PD simulation studySylvain Goutelle, Vincent Jullien, Jean-Pierre Bru, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2019
Low Central Nervous System Posaconazole Concentrations during Cerebral PhaeohyphomycosisFrançois Barde, Eliane Billaud, Lauriane Goldwirt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Predictive factors of virologic success in HIV-1-infected children treated with lopinavir/ritonavirConstance Delaugerre, Jean-Paul Teglas, Jean-Marc Treluyer, et al.
Antimicrobial Agents and Chemotherapy|September 16, 2009
Therapeutic drug monitoring of posaconazole: a monocentric study with 54 adultsDavid Lebeaux, Fanny Lanternier, Caroline Elie, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 29, 2021
Influence of the clindamycin administration route on the magnitude of clindamycin-rifampicin interaction: a prospective pharmacokinetic studyValérie Zeller, Sophie Magreault, Beate Heym, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2018
Is It Time for Systematic Voriconazole Pharmacogenomic Investigation for Central Nervous System Aspergillosis?François Danion, Vincent Jullien, Claire Rouzaud, et al.
The Journal of Antimicrobial Chemotherapy|June 28, 2014
Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in UgandaFrank Kloprogge, Vincent Jullien, Patrice Piola, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Posaconazole Tablets in Real-Life Lung Transplantation: Impact on Exposure, Drug-Drug Interactions, and Drug Management in Lung Transplant Patients, Including Those with Cystic FibrosisManon Launay, Antoine Roux, Laurence Beaumont, et al.
Pageof 13